HPLE EXCIPIENTS
Live / Registered — Registered (as of 26 Jan 2021)
What this means for you
Registered since 26 Jan 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87608792
- Registration number
- 6257475
- Mark type
- Stylized text
- Filed
- 14 Sept 2017
- Published for opposition
- 03 Jul 2018
- Registered
- 26 Jan 2021
- Attorney of record
- Paul C. Llewellyn
Goods and services
- Class 001 — Chemicals: Chemicals and biochemicals for use in the formulation, development and manufacture of pharmaceuticals, biopharmaceuticals, vaccines, finished drug products, parenteral drugs and therapies; Chemicals and biochemicals for use in biotechnological product development and manufacturing processes; excipients and active ingredients for use in development, formulation and manufacture of pharmaceuticals, biopharmaceuticals, vaccines, injectable formulations, pharmaceutical intermediaries and drug formulations; chemicals, biochemicals, stabilizers, catalysts, enzymes, formulation ingredients, additives, drug delivery molecules and carriers, and buffers, all for use in the pharmaceutical and biopharmaceutical industry; active pharmaceutical ingredients for use in the manufacture of pharmaceuticals, biopharmaceuticals, vaccines, and finished drug products; formulation ingredients, additives, drug delivery molecules, and carriers, and buffers, all for use in the pharmaceutical and biopharmaceutical industry; pharmaceutical intermediates for use in the pharmaceutical and biopharmaceutical industry; biochemical excipients for use in the pharmaceutical and biopharmaceutical industry; biochemical catalysts; biochemical preservers and protectors for use in the pharmaceutical and biopharmaceutical industry
- Class 042 — Scientific and technological services: Biochemical research and development; Chemical, biochemical, biological and bacteriological research and analysis; Drug discovery services; Pharmaceutical drug development services; Product research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of vaccines and medicines
Owner
- Pfanstiehl, Inc., Waukegan, IL, US
- Pfanstiehl, Inc., Waukegan, IL, US
- Pfanstiehl, Inc., Waukegan, IL, US
Prosecution history
- 26 Jan 2026 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 26 Jan 2021 — REGISTERED-PRINCIPAL REGISTER
- 23 Dec 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 22 Dec 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 03 Dec 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 03 Dec 2020 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 03 Dec 2020 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 02 Oct 2020 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 02 Oct 2020 — NON-FINAL ACTION E-MAILED
- 02 Oct 2020 — SU - NON-FINAL ACTION - WRITTEN
- 15 Sept 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Sept 2020 — STATEMENT OF USE PROCESSING COMPLETE
- 28 Aug 2020 — USE AMENDMENT FILED
- 14 Sept 2020 — SOU EXTENSION 4 GRANTED
- 28 Aug 2020 — SOU EXTENSION 4 FILED